Frontlight ResearchEarly access
CompletedNo phase
GDF15 in Anorexia Nervosa
Key facts
- Who runs it
- Karolinska Institutet
- Where
- Sweden1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 200 people enrolled
- Started
- 23 Jan 2017
- Ended
- 4 Nov 2024
- Type of study
- Observational, 3 groups
- Record updated
- 11 June 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- active DSMV diagnosis of anorexia nervosa/ at least two years of recovery from DSMV anorexia nervosa / no history of anorexia nervosa
Who cannot take part
- male
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Evaluating plasma levels of a protein called GDF15 in active and recovered anorexia nervosa, as well as healthy controls
The 3 groups in the trial
- active anorexia nervosa
- recovered anorexia nervosa
- healthy controls
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Elevated Plasma GDF15 Combined With FGF21 Suggests Mitochondrial Dysfunction in a Subgroup of Anorexia Nervosa Patients
- Record updated
- 11 June 2025